The ESOP Section 1042 Rollover

How it works

An ESOP, an employee stock ownership plan, is, before anything else, a qualified retirement plan: a stock bonus plan qualified under section 401(a) and required by section 4975(e)(7) to invest primarily in the stock of the company that sponsors it. It is not a buyer in the sense a private equity fund or a competitor is a buyer. It is a tax-exempt trust, run for the employees' benefit, that happens to be capable of purchasing the company's stock. The seller's tax benefit under section 1042 exists because Congress wants an owner who is selling anyway to sell to that trust instead of an outside buyer.

Most of these transactions are leveraged. The company, or a bank lending to the company, makes an outside loan to fund the purchase, then re-lends that money to the ESOP trust on matching terms, an inside loan. That two-step would ordinarily be a prohibited transaction between a plan and its own sponsor; section 4975(d)(3) exempts a loan to an ESOP that primarily benefits participants, charges a reasonable rate, and is collateralized only by the employer's own stock. The trust uses the proceeds to buy the stock from the selling owner. Purchased shares do not go straight into employee accounts; they sit in a suspense account as loan collateral, released to participant accounts as the company makes deductible contributions and the ESOP repays it, under Treas. Reg. section 54.4975-7(b). Employees never write a check. The company's own future cash flow funds the buyout over the loan's term, while the seller is paid on the loan's own schedule.

The seller's payoff sits in section 1042. Rather than paying capital-gains tax on the sale, an owner who sells qualified stock to the ESOP can elect to defer that gain by reinvesting the proceeds in qualified replacement property, meaning securities of other domestic operating companies, within a defined window around the sale. Held long enough, specifically until death, the deferred gain can disappear entirely. Section 1042(e)(3)(B) keeps a transfer at death from counting as a taxable disposition of the replacement property, and section 1014's ordinary basis step-up at death then resets the heirs' basis to fair market value, so gain that was only deferred while the seller was alive is never taxed to anyone. Sell the replacement property during life, for any reason other than a short list of exceptions (death, a gift, certain reorganizations, or another section 1042 transaction), and the deferred amount comes back into income that year under section 1042(e)(1), overriding the nonrecognition treatment that would otherwise apply.

What this is worth in Florida

Florida has no individual income tax, so the seller's side of this calculation is entirely federal. There is no state layer to plan around on the gain, deferred or eventually forgiven, or on whatever income the replacement securities produce while the seller holds them. If a Florida owner is being sold a state-tax angle on an ESOP sale, there is not one to sell; the planning value here is federal, full stop.

Who this applies to

This is not available to most business owners, and the gates are specific enough that they do most of the screening before a valuation conversation ever starts.

• The company must be a domestic C corporation. Qualified securities under section 1042 are employer securities issued by a domestic C corporation with no stock readily tradable on an established securities market. An S corporation cannot be the issuer for a full deferral, for any sale closing before January 1, 2028. A narrow exception opens after that date: section 1042(h), added by the SECURE 2.0 Act, lets an S-corp seller defer gain on only 10% of the amount realized, no matter how much is reinvested, with the other 90% taxed in the year of sale regardless. Before that date, the only route in is revoking the S election and selling as a C corporation, a trade-off I look at in my guide to the capital-gains options for selling a business and my Florida S-corp guide.
• The seller must have held the stock for at least three years as of the sale date, and the stock cannot have come to the seller through a distribution from a qualified plan or through a stock option or restricted stock award.
• The ESOP has to end up owning a real stake. Immediately after the sale, it must hold at least 30% of each class of the company's outstanding stock, or 30% of the total value of all outstanding stock, applying the section 318(a)(4) attribution rules. A sale into an ESOP that already clears 30% can be small; a brand-new ESOP's first purchase has to reach 30% on its own.
• Who this does not fit. A seller unwilling to accept an appraisal-driven price instead of one set by a competitive sale process should not expect to like the outcome here. Below a certain size, the fixed cost of a trustee, an independent appraiser, and ongoing plan administration is hard to justify against the deferral it buys; this is built for a company with real enterprise value behind it, not a marginal benefit for every small business.

Weigh it against an installment sale to an outside buyer before going further. An installment note spreads gain over years but never eliminates it, and it carries none of this strategy's ERISA fiduciary exposure or reinvestment-window discipline. What it cannot do is produce a permanent result the way an ESOP rollover held to death can.

What it requires

Beyond the eligibility gates above, the transaction itself has to clear a further set of thresholds once it is underway.

• The replacement-property window. Sale proceeds must go into qualified replacement property within a period that begins three months before the sale date and ends twelve months after it.
• What counts as qualified replacement property. A security of another domestic operating company, one that did not derive more than 25% of its prior year's gross receipts from passive investment income, and one that is not the company whose stock was sold or a member of its controlled group.
• The employer's consent. Before the seller can elect, the corporation must file a verified written statement consenting to the excise-tax exposure under sections 4978 and 4979A described below, bargained for at the same table as the sale.
• A timely, complete election. The seller attaches a statement of the election, the employer's consent statement, and a statement identifying the replacement property to the return for the year of sale, due (with extensions) by that return's deadline. It does not flex: an incomplete filing forfeits the deferral even where every economic condition was met.

Reinvestment does not have to be all or nothing. Gain is recognized only to the extent the amount realized exceeds the cost of the replacement property purchased, so a partial reinvestment still defers the rest, and whatever is left in cash is simply taxed as long-term capital gain for the year of sale. Gain that escapes recognition this way reduces the basis of the replacement property by the same amount, so the deferral is a basis-shifting mechanism rather than a true exclusion.

What you need to document

The paperwork here decides two different things: whether the election survives IRS scrutiny, which is largely mechanical, and whether the price the seller was paid survives a Department of Labor review of the ESOP trustee's fiduciary conduct, which is not.

An independent appraisal

Because the stock is not publicly traded, the initial sale price, every annual valuation afterward, and every later repurchase depend on an appraisal that can stand up as a fair transaction between a retirement plan and its own sponsor. This is the document a Department of Labor review actually turns on.

The employer's consent statement

The verified written statement consenting to sections 4978 and 4979A exposure, filed before the seller's election is made.

The election-year filings

A statement of the section 1042 election and a statement identifying the replacement property purchased, its issuer, purchase date, and cost, both attached to the return for the year of sale.

A basis ledger for the replacement property

The original cost of each purchase and the reduction for gain not recognized because of it, allocated across purchases by cost when there is more than one. This ledger is what determines the taxable gain whenever the property is eventually sold, or what basis passes to the heirs if it is instead held to death.

Where it goes wrong

This is not a listed transaction, and an IRS exam of the election is largely a documents check. The real risk runs in three other directions at once, and all three are worth naming before anyone treats this as a settled plan.

The seller's own allocation risk

Section 409(n) bars the sold stock's allocations, during a defined nonallocation period, from reaching the selling taxpayer or close relatives, and, with no time limit at all, from reaching anyone who owns more than 25% of any class of the company's stock, counting attribution; a narrow exception lets lineal descendants receive up to 5% in the aggregate. A violation triggers a 50% excise tax under section 4979A, paid by the employer rather than the seller, but it falls on the same company the seller usually still has a relationship with, as a remaining shareholder, a board member, or simply someone whose reputation is tied to the deal.

The employer's disposition and repurchase exposure

If the ESOP disposes of the section 1042 stock within three years of buying it, and either the share count drops below what it held right after the sale or the value of ESOP-held stock falls below 30% of the company's total employer securities, the employer owes a 10% excise tax on the amount realized under section 4978, with exceptions for death, retirement after fifty-nine and a half, disability, a one-year break in service, or certain reorganizations. Separately, because the stock cannot be traded on an open market, section 409(h) requires that distributions from the plan carry a put option: the participant can require the company to buy the shares back at a fair-valuation price, held open across two sixty-day windows, with payment on a full distribution allowed to spread across as many as five years. That repurchase obligation only grows as the workforce ages, and a company with no funding plan behind it is carrying what is the single biggest threat to the ESOP's, and the company's, long-term viability.

Valuation risk, the least resolved of the three

Every price in this transaction, the sale itself, the annual valuations, the eventual repurchases, rests on an appraisal, and there has never been a final regulation defining what makes that appraisal adequate for a deal between a retirement plan and its own sponsor. A proposed rule surfaced briefly in January 2025 and was frozen before taking effect. In its place, the operative standard comes from years of Department of Labor enforcement against trustees and appraisers who signed off on prices favoring the selling shareholder over the plan, and that is the exposure that actually decides whether a sale holds up, more than anything on the seller's own return.

A situation where this comes up

The owner I see reach for this is usually not chasing the tax deferral first. They are somewhere in their sixties, running a company with no obvious buyer waiting in the wings, no family member who wants it, and a genuine reluctance to hand the business and its employees to a private equity buyer who will likely relocate, consolidate, or resell it within a few years. The deferral is real and it matters, but it becomes the deciding factor only after the ownership question is already leaning this way.

What usually surprises that owner is the valuation conversation. They come in with a number in mind, often one a competitor floated informally, and the ESOP trustee is not free to simply agree to it. The trustee owes an independent fiduciary duty to the plan, has to hire its own appraiser, and has to be able to defend that price years later if the Department of Labor ever asks. That process reads as slower and more adversarial than a negotiation with a single buyer who just wants the deal to close, and sellers who go in expecting a rubber stamp are the ones most likely to come away frustrated, even when the eventual price is fair.

The version that worries me is the smaller company sized for the tax benefit rather than for the structure. An appraiser, a trustee, ERISA counsel, and a lender who actually understands ESOP financing are not optional participants, and none of them work for free. A seller chasing the deferral on a company too small to carry those costs, and too small to fund the repurchase obligation a decade later, is buying a complicated, expensive path to a result an outright sale or an installment note would have reached more simply. The gates in this strategy filter who can use it. They do not filter who should.